Castle Biosciences

-$0.91 (-1.43%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CSTL and other ETFs, options, and stocks.

About CSTL

Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma.

CEO
Derek J. Maetzold
Employees
201
Headquarters
Friendswood, Texas
Founded
2007

CSTL Key Statistics

Market Cap
1.58B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
140.22K
High Today
$64.50
Low Today
$61.23
Open Price
$63.50
Volume
151.02K
52 Week High
$107.69
52 Week Low
$43.37

CSTL Earnings

-$0.40
-$0.26
-$0.11
$0.03
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure